These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36008534)

  • 1. The antimicrobial effects of PLGA microspheres containing the antimicrobial peptide OP-145 on clinically isolated pathogens in bone infections.
    Cheng Y; Qin J; Huang Y; Wang T
    Sci Rep; 2022 Aug; 12(1):14541. PubMed ID: 36008534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionalized PLGA Microsphere Loaded with Fusion Peptide for Therapy of Bone Defects.
    Xu S; Tian G; Zhi M; Liu Z; Du Y; Lu X; Li M; Bai J; Li X; Deng J; Ma S; Wang Y
    ACS Biomater Sci Eng; 2024 Apr; 10(4):2463-2476. PubMed ID: 38445948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of intertrochanteric bone quality in osteoporotic female rats after injection of polylactic acid-polyglycolic acid copolymer/collagen type I microspheres combined with bone mesenchymal stem cells.
    Yu Z; Zhu T; Li C; Shi X; Liu X; Yang X; Sun H
    Int Orthop; 2012 Oct; 36(10):2163-71. PubMed ID: 22539160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial Activity of 3D-Printed Poly(ε-Caprolactone) (PCL) Composite Scaffolds Presenting Vancomycin-Loaded Polylactic Acid-Glycolic Acid (PLGA) Microspheres.
    Zhou Z; Yao Q; Li L; Zhang X; Wei B; Yuan L; Wang L
    Med Sci Monit; 2018 Sep; 24():6934-6945. PubMed ID: 30269152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(lactic acid-co-glycolic acid)-based celecoxib extended-release microspheres for the local treatment of traumatic heterotopic ossification.
    Lin J; Huang J; Wu J; Tang B; Li C; Xiao H
    J Biomater Appl; 2022 Mar; 36(8):1458-1468. PubMed ID: 35043696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo.
    Qiao C; Zhang K; Jin H; Miao L; Shi C; Liu X; Yuan A; Liu J; Li D; Zheng C; Zhang G; Li X; Yang B; Sun H
    Int J Nanomedicine; 2013; 8():2985-95. PubMed ID: 23990717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient aqueous remote loading of peptides in poly(lactic-co-glycolic acid).
    Giles MB; Hong JKY; Liu Y; Tang J; Li T; Beig A; Schwendeman A; Schwendeman SP
    Nat Commun; 2022 Jun; 13(1):3282. PubMed ID: 35676271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained delivery of rhBMP-2 by means of poly(lactic-co-glycolic acid) microspheres: cranial bone regeneration without heterotopic ossification or craniosynostosis.
    Wink JD; Gerety PA; Sherif RD; Lim Y; Clarke NA; Rajapakse CS; Nah HD; Taylor JA
    Plast Reconstr Surg; 2014 Jul; 134(1):51-59. PubMed ID: 24622573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.
    Wang N; Wu XS; Li JK
    Pharm Res; 1999 Sep; 16(9):1430-5. PubMed ID: 10496661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in angiogenesis and osteogenesis with modified cannulated screws combined with VEGF/PLGA/fibrin glue in femoral neck fractures.
    Zhang L; Zhang L; Lan X; Xu M; Mao Z; Lv H; Yao Q; Tang P
    J Mater Sci Mater Med; 2014 Apr; 25(4):1165-72. PubMed ID: 24435526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic profiles of recombinant human erythropoietin-loaded poly(lactic-co-glycolic acid) microspheres in rats.
    Zhou XL; He JT; Du HJ; Fan YY; Wang Y; Zhang HX; Jiang Y
    Acta Pharmacol Sin; 2012 Jan; 33(1):137-44. PubMed ID: 22139004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLGA Microspheres Containing Hydrophobically Modified Magnesium Hydroxide Particles for Acid Neutralization-Mediated Anti-Inflammation.
    Kim JK; Go EJ; Ko KW; Oh HJ; Han J; Han DK; Park W
    Tissue Eng Regen Med; 2021 Aug; 18(4):613-622. PubMed ID: 33877618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic study of taxol-loaded poly(lactic-co-glycolic acid) microspheres containing isopropyl myristate after targeted delivery to the lung in mice.
    Sato H; Wang YM; Adachi I; Horikoshi I
    Biol Pharm Bull; 1996 Dec; 19(12):1596-601. PubMed ID: 8996646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugation of drug to poly(D,L-lactic-co-glycolic acid) for controlled release from biodegradable microspheres.
    Oh JE; Nam YS; Lee KH; Park TG
    J Control Release; 1999 Feb; 57(3):269-80. PubMed ID: 9895414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of gelatin surface modified PLGA microspheres.
    Tsung MJ; Burgess DJ
    AAPS PharmSci; 2001; 3(2):E11. PubMed ID: 11741261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of a wound-healing agent from PLGA microspheres in a thermosensitive gel.
    Machado HA; Abercrombie JJ; You T; Deluca PP; Leung KP
    Biomed Res Int; 2013; 2013():387863. PubMed ID: 24224161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged Plasma Exposure of the Kv1.3-Inhibitory Peptide HsTX1[R14A] by Subcutaneous Administration of a Poly(Lactic-co-Glycolic Acid) (PLGA) Microsphere Formulation.
    Jin L; Pan Y; Pham AC; Boyd BJ; Norton RS; Nicolazzo JA
    J Pharm Sci; 2021 Mar; 110(3):1182-1188. PubMed ID: 33065128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres.
    Cleland JL; Mac A; Boyd B; Yang J; Duenas ET; Yeung D; Brooks D; Hsu C; Chu H; Mukku V; Jones AJ
    Pharm Res; 1997 Apr; 14(4):420-5. PubMed ID: 9144725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A biomimetic approach to active self-microencapsulation of proteins in PLGA.
    Shah RB; Schwendeman SP
    J Control Release; 2014 Dec; 196():60-70. PubMed ID: 25219750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative biocompatibility study of microspheres based on crosslinked dextran or poly(lactic-co-glycolic)acid after subcutaneous injection in rats.
    Cadée JA; Brouwer LA; den Otter W; Hennink WE; van Luyn MJ
    J Biomed Mater Res; 2001 Sep; 56(4):600-9. PubMed ID: 11400139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.